What is MariMed?
Established in 2011 and headquartered in Massachusetts, MariMed operates as a sophisticated management service provider within the medical cannabis industry. The company specializes in the end-to-end lifecycle of cannabis facilities, encompassing the design, development, financing, and operational optimization of cultivation, production, and dispensary assets. By positioning itself as a critical partner for facility management, MariMed leverages deep regulatory expertise and technical proficiency to navigate the complex, fragmented landscape of state-legalized cannabis markets. Its business model is designed to mitigate operational risks while maximizing yield and compliance, effectively serving as a cornerstone for institutional-grade cannabis infrastructure development.
How much funding has MariMed raised?
MariMed has raised a total of $85M across 3 funding rounds:
Debt
$4M
Share Placement
$46M
Debt
$35M
Debt (2017): $4M, investors not publicly disclosed
Share Placement (2021): $46M led by Hadron
Debt (2023): $35M supported by Chicago Atlantic Group
Key Investors in MariMed
Chicago Atlantic Group
Chicago Atlantic is a credit and equity-focused investing platform that targets time-sensitive, complex, and dislocated market opportunities where risk is mispriced.
Hadron
An investment firm focused on strategic capital allocation and supporting growth-stage enterprises across diverse sectors.
Undisclosed Investor
An institutional participant providing debt financing to support the company's ongoing operational and facility development requirements.
What's next for MariMed?
With the infusion of this latest capital, MariMed is well-positioned to accelerate its strategic expansion and enhance its competitive advantage in the multi-state cannabis arena. The company is expected to prioritize the scaling of its production capabilities and the refinement of its dispensary network to capture increasing market demand. By focusing on operational efficiency and capital deployment in underserved sectors, MariMed aims to solidify its market position as a leader in cannabis facility management. Future growth initiatives will likely center on leveraging its existing infrastructure to drive long-term value, navigating evolving regulatory frameworks, and maintaining its trajectory as a high-growth entity in the cannabis sector.
See full MariMed company page
